Daily Tech News, Interviews, Reviews and Updates

First Neuralink Product Is Called Telepathy, Musk Announced

Elon Musk in a recent tweet announced its first Neuralink product that will be called “Telepathy”. He further wrote that it “enables the control of your phone or computer and through almost any device, just by thinking”.

He has mentioned that the initial users of this breakthrough technology will be those who have lost the use of their limbs which has always been a mission and epicenter of this technology. To emphasize its importance he gave the example of Stephen Hawking and wrote “Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer”.

In an earlier X post, Musk wrote about the first human receiving the implant from Neuralink who was recovering well. And the initial results as per the post were good for the team as they showed promising neuron spike detection.

This is a significant milestone achieved by the company that Musk founded in 2016 with the mission to “create a generalized brain interface to restore the autonomy to those with unmet medical needs today” and to unlock the human potential tomorrow.

Its brain-computer implantable interface known as “Link” requires surgery and is made of multiple components. This implant’s biocompatible enclosure has got a battery, chips, and electronics, highly flexible threads, and ultra-thin.

Readers like you help support The Tech Outlook. When you make a purchase using links on our site, we may earn an affiliate commission. We cannot guarantee the Product information shown is 100% accurate and we advise you to check the product listing on the original manufacturer website. Thetechoutlook is not responsible for price changes carried out by retailers. The discounted price or deal mentioned in this item was available at the time of writing and may be subject to time restrictions and/or limited unit availability. Amazon and the Amazon logo are trademarks of Amazon.com, Inc. or its affiliates Read More
You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More